Ghostwriting in Medical Journals
Author Information
Author(s): Leemon McHenry
Primary Institution: California State University, Northridge
Hypothesis
The pharmaceutical marketing objectives and use of medical communication firms in the production of ghostwritten articles constitute a new form of sophistry.
Conclusion
Ghostwriting undermines the integrity of academic medicine and can harm patients by distorting the profile of drugs.
Supporting Evidence
- Over 50% of published clinical trials may be ghostwritten.
- Ghostwriting can lead to manipulation of results by selective reporting of data.
- Pharmaceutical companies often use ghostwriters to create articles that promote their products.
Takeaway
Some companies secretly write articles for doctors to put their names on, which can make medicines look better than they really are.
Methodology
The paper surveys known cases of ghostwriting and discusses its implications for academic medicine.
Potential Biases
The pharmaceutical industry may manipulate data to favor their products.
Limitations
The true extent of ghostwriting is unknown due to its hidden nature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website